What's breaking now, across thousands of outlets.
Key PointsForecasts call for Teva's branded drug portfolio to bring it $3.7 billion in revenue next year.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Somewhere along the way, care coordination quietly became the patient's responsibility.
High blood pressure and diabetes are taking a massive toll on health in the South African population. Dr Nasheeta Peer breaks down what it will take to tackle the growing crisis.
Breast cancer survivor Agnes Munien reflects on fighting the disease twice and the lifesaving power of early detection after being honoured on Temba Bavuma’s jersey at the Wanderers Pink ODI.
[New Era] Chinchimani -- Zambezi Governor Dorothy Kabula has raised alarm over the sharp increase in malaria cases in the region, with 33 349 cases recorded by the week ending 12 September 2026 since…
(Thanasis/Moment RF/Getty Images) There's reason to tread cautiously. Don't miss a story, subscribe here.
In a study published in Cancer Discovery, cancer neoantigens and neoantigen-specific T cells were identified from patient blood samples by analyzing circulating tumor DNA (ctDNA) and immune cells.
